Dipna Pharmachem Ltd

BSE : Dipna_Pharmachem15 Jan 2025

Pharmaceuticals

₹

-0.61 (-4.04%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Dipna Pharmachem Ltd

Dipna Pharmachem Ltd

Pharmaceuticals

BSE : Dipna_Pharmachem15 Jan 2025

₹

-0.61 (-4.04%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
31-Jan-2024	R	13:12 Rights Issues Of Equity Shares Trading Members of the Exchange are hereby informed that DIPNA PHARMACHEM LIMITED has fixed Record date for the purpose of Rights Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company should be done on Ex-Rights basis with effect from the under mentioned date: DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE DIPNA PHARMACHEM LIMITED (543594) RECORD DATE 12/02/2024 PURPOSE Issue of 13 (Thirteen) Equity Shares of Rs.10 each for cash AT PAR on Rights Basis for every 12 (Twelve) Equity Shares held. Ex-Right basis from Date & Sett. No. 12/02/2024 DR-715/2023-2024 (As Per BSE Notice dated on 06.02.2024)	12-Feb-2024	13:12
11-Dec-2024	BC	Outcome of Board Meeting held today i.e. 11th December, 2024	11-Dec-2024
13-Nov-2024	BC	Kindly find the attached intimation	13-Nov-2024
06-Nov-2024	BC	Kindly find the attached intimation regarding Resignation of Independent Director of the Company.	06-Nov-2024
27-Nov-2024	BC	Kindly find the attached intimation of Resignation of Company Secretary	31-Oct-2024
11-Oct-2024	BC	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held	11-Oct-2024

Record Date01 Jan'1900

Ex-Rights Date01 Jan'1900

Premium(Rs.)0

Ratio13:12

Book Closure

Record Date	Split Date	Purpose
11-Dec-2024	-	Outcome of Board Meeting held today i.e. 11th December, 2024
13-Nov-2024	-	Kindly find the attached intimation
06-Nov-2024	-	Kindly find the attached intimation regarding Resignation of Independent Director of the Company.
31-Oct-2024	-	Kindly find the attached intimation of Resignation of Company Secretary
11-Oct-2024	-	Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Dipna Pharmachem Ltd ₹14.50(-0.61/-4.04%)	14.50	-0.61	36.33	44.73	33.58	0.97
Bliss GVS Pharma Ltd ₹159.20(-4.50/-2.75%)	159.20	-4.50	1,724.85	24.25	21.34	1.68
Amrutanjan Health Care Ltd ₹677.70(-26.20/-3.72%)	677.70	-26.20	2,035.02	17.78	42.82	6.83
Astrazeneca Pharma India Ltd ₹6,731.95(-298.40/-4.24%)	6,731.95	-298.40	17,575.88	13.50	136.54	25.87
Abbott India Ltd ₹27,763.95(-491.60/-1.74%)	27,763.95	-491.60	60,043.04	7.81	46.74	17.05
Ambalal Sarabhai Enterprises Ltd ₹50.49(-0.93/-1.81%)	50.49	-0.93	394.05	-1.08	44.71	8.74

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash and Cash Equivalents at Beginning of the year	5.69	0.21	0.25	0.18	0.12
Net Cash from Operating Activities	-5.42	-20.98	2.81	-2.43	-3.12
Net Cash Used In Investing Activities	-0.01	-0.01	-0.01	0.00	0.01
Net Cash Used In Financing Activities	13.62	26.47	-2.84	2.50	3.17
Net Inc./Dec In Cash And Cash Equivalents	8.19	5.48	-0.04	0.08	0.06
Cash And Cash Equivalents At End Of The Year	13.88	5.69	0.21	0.25	0.18

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

9.98%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

90.02%

**Promoter pledged shareholding 9.98%

About Dipna Pharmachem Ltd

Dipna Pharmachem Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 36.33 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Keyur Shah,Dipna Shah,Nandish Jani,Chinu Kalal,Jitendra Parmar (Dipna Pharmachem Ltd) among others.

Chairman

Registered office

A/211 Siddhi Vinayak Complex,Near D A V School Makarba,Ahmedabad,Gujarat,380055

FAX :

Background

Incorporation Year2011

Face Value₹10

Market Lot3000